Screening for gestational diabetes mellitus in Nigerian pregnant women using fifty-gram oral glucose challenge test. 2008

O Adegbola, and G O Ajayi
Department of Obstetrics and Gynaecology, College of Medicine, University of Lagos/Lagos University Teaching Hospital, Nigeria. Omololuadegbola@Yahoo.com

BACKGROUND Gestational Diabetes Mellitus (GDM) is frequently associated with adverse pregnancy outcome if not adequately managed. Prompt identification of these women requires a programme of active screening. OBJECTIVE To determine the predictive value of the oral 50-gram glucose challenge test (GCT) in the detection of GDM. METHODS At 24 to 28 weeks of gestation, 134 pregnant women with risk factors for GDM (test group) and another group of 134 consecutive pregnant women without risk factors for GDM (control group) were screened with 50 grams of anhydrous glucose and venous blood obtained one hour later. A diagnostic 3-hour - 100g oral glucose tolerance test (OGTT) was done for all either within one week for those with GCT > or = 130mg/dl (7.2mmol/L) or at 30 to 32 weeks of gestation for those with GCT of less than 130mg/dll RESULTS Of the 134 women in the test group 113 (84.3%) completed the study, as did 109 (81.3%) of the 134 women in the control group. The data from these women were analyzed. Gestational diabetes mellitus was found in 7 (6.2 %) of the test group and 5 (4.6 %) of the control group (p = 0.816), an overall prevalence of 12 (5.4 %) for the study. Among the women with newly diagnosed GDM, 58% had risk factors for glucose intolerance while 42% had no such risk factors. The sensitivity and negative predictive values were all 100% at screening values of 130mg/dl and 140mg/dl; while the specificity was 82.4% at 130mg/dl and 91% at 140mg/dl. This was however not statistically significant (p = 0.619). CONCLUSIONS The plasma glucose value of 140mg/dl in the GCT should be used because of its high sensitivity and higher specificity than does the 130mg/dl screening value. GDM is unlikely to be present if the venous plasma glucose level is less than 140mg/dl, one hour after administration of 50g oral glucose load at 24 to 28 weeks gestational age.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D009549 Nigeria A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja. Federal Republic of Nigeria
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

O Adegbola, and G O Ajayi
August 1993, Singapore medical journal,
O Adegbola, and G O Ajayi
October 2016, Journal of obstetrics and gynaecology of India,
O Adegbola, and G O Ajayi
February 2011, Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia,
O Adegbola, and G O Ajayi
September 2011, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
O Adegbola, and G O Ajayi
December 2007, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
O Adegbola, and G O Ajayi
January 2005, Journal of Ayub Medical College, Abbottabad : JAMC,
O Adegbola, and G O Ajayi
May 2006, American journal of obstetrics and gynecology,
Copied contents to your clipboard!